Results 221 to 230 of about 59,353 (325)

Metastatic Renal Cell Carcinoma (RCC) [PDF]

, 1991
A. V. Bono, C. Stief, D. E. Johnson, D. G. Skinner, D. H. Garfield, D. J. Fairlamb, D. W. McNichols, E. Allhoff, G. L. Rohdenburg, G. T. Hultquist, H. C. Bumpus Jr., H. E. Stephenson Jr., H. J. G. Bloom, H. J. G. Bloom, H. J. G. Bloom, H. Takatera, I. Satake, J. B. Kernion De, J. B. Kernion De, J. C. Donaldson, J. E. Montie, K. Goldenberg, L. R. Kavoussi, M. M. Mims, R. C. Klugo, R. G. Middleton, R. M. Snow, R. Schlick, S. E. Katz, S. Liedke, S. Z. Freed, T. C. Everson, U. Jonas, W. de Riese, Z. Wajsman   +34 more
core   +1 more source

Robotic Tumor Debulking off External Iliac Vessels for the Management of Recurrent Ovarian Cancer [PDF]

, 2019
Levent Mutlu, Wafa Khadraoui, Tarek Khader, Gulden Menderes   +3 more
openalex   +1 more source

Role of systematic lymphadenectomy as part of primary debulking surgery for optimally cytoreduced advanced ovarian cancer: Reappraisal in the era of radical surgery

, 2016
Kyung Jin Eoh, Jung‐Yun Lee, Jung Won Yoon, Eun Ji Nam, Sunghoon Kim, Sang Wun Kim, Young Tae Kim   +6 more
openalex   +2 more sources

The Landmark Series: Surgical Management of Functioning and Non-Functioning Pancreatic Neuroendocrine Tumors. [PDF]

Ann Surg Oncol
Tobias J, Clarke CN, Gangi A, Keutgen XM.   +3 more
europepmc   +1 more source

Prognostic nomogram for advanced epithelial ovarian cancer in the era of homologous recombination testing and PARP inhibitor therapy. [PDF]

Am J Cancer Res
Lin H, Ou YC, Fu HC, Tsai CC, Wang YW, Chen YY, Huang SW, Wu CH.   +7 more
europepmc   +1 more source

Erratum: Bowel resection rate but not bowel related morbidity is decreased after interval debulking surgery compared to primary surgery in patents with stage IIIC–IV ovarian cancer [PDF]

, 2019
Roberto Tozzi, Jvan Casarin, Ahmet Baysal, Gaetano Valenti, Yakup Kilic, Hooman Soleymani majd, Matteo Morotti   +6 more
openalex   +1 more source

OV21/PETROC: a randomized Gynecologic Cancer Intergroup phase II study of intraperitoneal versus intravenous chemotherapy following neoadjuvant chemotherapy and optimal debulking surgery in epithelial ovarian cancer

Annals of Oncology, 2018
D. Provencher, C. Gallagher, W. Parulekar, J. Ledermann, D. Armstrong, M. Brundage, C. Gourley, I. Romero, A. González-Martín, M. Feeney, P. Bessette, M. Hall, J. Weberpals, G. Hall, S. Lau, P. Gauthier, M. Fung-Kee-Fung, M. Fung-Kee-Fung, E. Eisenhauer, C. Winch, D. Tu, H. Mackay   +21 more
semanticscholar   +1 more source

A Tumultuous Journey of Metastatic Pancreatic Neuroendocrine Tumor with Carcinoid Syndrome. [PDF]

J ASEAN Fed Endocr Soc
Giri S, Kamalanathan S, Raja K, Pandit N, Naik D, Sahoo J.   +5 more
europepmc   +1 more source

Stable expansion of high-grade serous ovarian cancer organoids requires a low-Wnt environment

, 2020
Berger, H., Braicu, E., Chekerov, R., Darb-Esfahani, S., Hoffmann, K., Kessler, M., Kulbe, H., Mangler, M., Meyer, T., Mollenkopf, H., Sehouli, J., Taube, E., Thillainadarasan, S., Zemojtel, T.   +13 more
core   +1 more source

Neoadjuvant chemotherapy versus primary debulking surgery in advanced epithelial ovarian cancer: A meta-analysis of peri-operative outcome

, 2017
Lijuan Yang, Bo Zhang, Guangyang Xing, Jingran Du, Bin Yang, Qianqian Yuan, Yongxiu Yang   +6 more
openalex   +2 more sources